Implementation of a Biological Sample Collection in Systemic Sclerosis Patients

Launched by UNIVERSITY HOSPITAL, LILLE · Jul 22, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on improving the care of patients with systemic sclerosis (SSc), a serious autoimmune disease that can cause hardening of the skin and affect organs like the lungs and heart. The researchers at Lille University Hospital aim to collect additional blood samples from patients during their regular check-ups. These samples will help identify new biological markers, or "biomarkers," that can predict how the disease progresses and how well patients respond to treatments. This information is important because it can lead to better management of SSc and help determine which patients may benefit most from new therapies.

To participate in the trial, you would need to be a patient receiving care for SSc at Lille University Hospital and meet certain criteria, such as being insured by the French social security system and being able to understand the study requirements. Participants can expect to provide two extra blood samples during their routine evaluations, which typically happen once a year. This study is not yet recruiting participants, but it represents an important step toward improving outcomes for those living with systemic sclerosis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient followed for SSc in the internal medicine or cardiology department of the Lille University Hospital
• • Fulfilling the ACR/EULAR and/or VEDOSS criteria for SSc
• • Being insured by the French social security system
• • Having the ability to understand the requirements of the study and provide informed consent
• Exclusion Criteria:
• • Administrative reasons: unable to receive informed information, lack of social security coverage
• • Pregnant or lactating women
• • Persons deprived of liberty
• • Minors or protected adults
• • Persons who have refused or are unable to give informed consent
• • Persons in emergency situations